Initially it appeared as though Triporelan was some kind of ultra risky treatment shrouded in mysticism but the treatment is published in a paper of the American Association of Clinical Endocrinologists outlining Guidelines for treatment of Hypogonadism, .a.k.a. Low Testosterone in adult male patients 2002. More specifically hypogonadic hypogonadism meaning possible suppression of the HP axis. (Post Cycle Therapy?) They also go on to specify one time dosage not to exceed 100 mcg.
I think where confusion exists regarding this treatment is that folks didn't understand the drug has many applications, one being prostate cancer where large and repeated doses are given far beyond the dose range used for low testosterone treatment. The insert for Trelstar (Pfizers brand name for Tripotorelan) is marketed specifically for treating prostate cancer but even in Trelstars product insert they say once the product is stopped testosterone production should resume.
It would seem the only challenging part remaining is having an endocrinologist prescribe the test. The obvious alternative would be web based product.